BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28509392)

  • 1. Aflatoxin B
    Chu YJ; Yang HI; Wu HC; Liu J; Wang LY; Lu SN; Lee MH; Jen CL; You SL; Santella RM; Chen CJ
    Int J Cancer; 2017 Aug; 141(4):711-720. PubMed ID: 28509392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aflatoxin B
    Chu YJ; Yang HI; Wu HC; Lee MH; Liu J; Wang LY; Lu SN; Jen CL; You SL; Santella RM; Chen CJ
    Eur J Cancer; 2018 May; 94():37-46. PubMed ID: 29533866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma.
    Chen CJ; Yu MW; Liaw YF; Wang LW; Chiamprasert S; Matin F; Hirvonen A; Bell DA; Santella RM
    Am J Hum Genet; 1996 Jul; 59(1):128-34. PubMed ID: 8659516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan.
    Wu HC; Wang Q; Yang HI; Ahsan H; Tsai WY; Wang LY; Chen SY; Chen CJ; Santella RM
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):846-53. PubMed ID: 19273485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
    Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
    Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan.
    Yu MW; Lien JP; Chiu YH; Santella RM; Liaw YF; Chen CJ
    J Hepatol; 1997 Aug; 27(2):320-30. PubMed ID: 9288607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of formation of aflatoxin-albumin adducts: a seven-township study in Taiwan.
    Sun CA; Wu DM; Wang LY; Chen CJ; You SL; Santella RM
    Br J Cancer; 2002 Oct; 87(9):966-70. PubMed ID: 12434285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, China.
    Qi LN; Li LQ; Chen YY; Chen ZH; Bai T; Xiang BD; Qin X; Xiao KY; Peng MH; Liu ZM; Liu TW; Qin X; Li S; Han ZG; Mo ZN; Santella RM; Winkler CA; O'Brien SJ; Peng T
    PLoS One; 2013; 8(12):e83465. PubMed ID: 24391771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aflatoxin B
    Alvarez CS; Hernández E; Escobar K; Villagrán CI; Kroker-Lobos MF; Rivera-Andrade A; Smith JW; Egner PA; Lazo M; Freedman ND; Guallar E; Dean M; Graubard BI; Groopman JD; Ramírez-Zea M; McGlynn KA
    BMJ Open Gastroenterol; 2020 Jul; 7(1):. PubMed ID: 32641287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure.
    Xiang X; Qin HG; You XM; Wang YY; Qi LN; Ma L; Xiang BD; Zhong JH; Li LQ
    Cancer Med; 2017 Oct; 6(10):2357-2369. PubMed ID: 28941211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan.
    Sun CA; Wang LY; Chen CJ; Lu SN; You SL; Wang LW; Wang Q; Wu DM; Santella RM
    Carcinogenesis; 2001 Aug; 22(8):1289-94. PubMed ID: 11470760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States.
    Wan DW; Tzimas D; Smith JA; Kim S; Araujo J; David R; Lobach I; Sarpel U
    Am J Gastroenterol; 2011 Nov; 106(11):1994-2000. PubMed ID: 21912436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males.
    Yu MW; Chiang YC; Lien JP; Chen CJ
    Carcinogenesis; 1997 Jun; 18(6):1189-94. PubMed ID: 9214602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
    Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
    Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.
    McGlynn KA; Rosvold EA; Lustbader ED; Hu Y; Clapper ML; Zhou T; Wild CP; Xia XL; Baffoe-Bonnie A; Ofori-Adjei D
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2384-7. PubMed ID: 7892276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection.
    Chu CM; Lin CC; Chen YC; Jeng WJ; Lin SM; Liaw YF
    Br J Cancer; 2012 Dec; 107(12):2010-5. PubMed ID: 23079574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of plasma aflatoxin B1-albumin adduct level with plasma selenium level and genetic polymorphisms of glutathione S-transferase M1 and T1.
    Chen SY; Chen CJ; Tsai WY; Ahsan H; Liu TY; Lin JT; Santella RM
    Nutr Cancer; 2000; 38(2):179-85. PubMed ID: 11525595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center study.
    Abdel-Wahab M; Mostafa M; Sabry M; el-Farrash M; Yousef T
    Hepatogastroenterology; 2008; 55(86-87):1754-9. PubMed ID: 19102385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.